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Abstract
Background: In patients with aortic stenosis (AS), increased afterload induces changes in
left ventricular (LV) geometry to preserve a normal ejection fraction (EF). Nevertheless, myo-
cardial dysfunction may occur in spite of a normal EF. Global longitudinal strain (GLS)
analysis can detect subtle contractile dysfunction at a pre-clinical stage. The aim of our study
was to assess LV function deteriorations with GLS analysis and the association with geomet-
ric changes in patients with AS and normal EF.
Methods: Forty four patients with moderate to severe AS and 40 controls were enrolled. All
patients underwent echocardiography, including two-dimensional strain imaging. The rela-
tive wall thickness and LV muscle mass measurements were performed with magnetic reso-
nance imaging and patients were subdivided into four groups: Group 1 with normal LV,
Group 2 with concentric remodeling, Group 3 with eccentric hypertrophy, and Group 4 with
concentric hypertrophy.
Results: The total group of patients with AS showed a GLS of –15.3 ± 3.6% while the control
group reached –18.9 ± 3.2% (p < 0.001). GLS was lower in the hypertrophy Groups 3 and
4 compared to Groups 1 and 2 (12.9 ± 3.4% vs 17.2 ± 2.5%, p < 0.05, respectively). Splitting
the patients into Groups 1 to 4, the GLS was –17.2 ± 2.4%, –17.2 ± 2.7%, –12.4 ± 3.8% and
–13.1 ± 3.3, respectively (p = 0.002).
Conclusions: In subjects with AS, lower GLS is related to LV hypertrophy, but not to the
presence of concentric remodeling. Assessment of GLS can identify subtle contractile dysfunc-
tion independent of a preserved EF, and might be useful in identifying patients at high risk for
the transition from compensatory to pathological remodeling. (Cardiol J 2011; 18, 2: 151–156)
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Introduction
Myocardial systolic function is usually assessed
by left ventricular ejection fraction (LVEF). Never-
theless, an abnormal EF is a late consequence of
chronically increased afterload such as it appears in
degenerative aortic stenosis (AS). Newer quantitative
techniques such as global longitudinal strain (GLS)
analysis and tissue Doppler imaging [1] have been
used to better characterize global myocardial systo-
lic function and detect subtle signs of myocardial dys-
function before bold changes in EF occur [2, 3].
In general, in patients with AS, the onset of
LV systolic dysfunction determines a poor prog-
nosis [4, 5]. Recent guidelines only focus on the
LVEF to define systolic function [6]. Despite this,
there is compelling evidence to suggest that even
in the presence of preserved or supranormal EF,
myocardial performance may be severely dysfunc-
tional in AS patients. Specifically, LV hypertrophy
(LVH) triggered by an increased afterload can
maintain a normal ejection performance despite
decreased intrinsic longitudinal function [7, 8]. In
addition, LVH, a very common finding in hyper-
tension and AS, has been proven to be an adverse
prognostic marker [9, 10].
Therefore, LVH can be beneficial in some re-
spects and harmful in others. The challenge for the
clinician is to detect contractile dysfunction at an
early subclinical point so as to prevent irreversible
myocardial function deterioration.
In AS, differences in the adaptive remodeling
of the LV have been described, but the influence of
LV geometry on the longitudinal systolic function
is not widely appreciated. We investigated the im-
pact of LV geometry on intramyocardial longitudi-
nal mechanics with magnetic resonance imaging
(MRI) and two-dimensional (2D) myocardial strain
(‘speckle tracking’) echocardiography.
Methods
This study was designed for patients with mode-
rate to severe AS who underwent conventional and
2D speckle tracking echocardiography as part of
a clinical trial protocol. A total of 44 patients were
enrolled. We included 40 age-matched control pa-
tients in order to establish normal GLS values for
our echo laboratory.
All patients gave their written informed con-
sent. The study protocol was approved by the local
ethics committee.
In subjects with AS, MRI was performed to
assess LV muscle mass, geometry and function.
Exclusion criteria were: concomitant mitral valve
disease, severe low gradient AS, EF < 35%, hyper-
trophic obstructive cardiomyopathy, uncontrolled
hypertension, severe ventricular arrhythmias, and
the general exclusion criteria for MRI.
Standard and tissue Doppler echocardiography
were done with a commercially available system
(Vingmed Vivid 7, General Electric, Milwaukee,
Wisconsin, USA). LVEF was calculated by the bi-
plane Simpson’s method. Deformation analysis of
the datasets was performed off-line using EchoPac
PC8.0 (General Electric-Vingmed). Longitudinal
strain measurements from the individual three api-
cal standard views were averaged to obtain a GLS
value [3].
MRI was done with a 1.5-Tesla Achieva scan-
ner (Philips Medical Systems, Netherlands)
equipped with a 5-element cardiac synergy coil.
Cine-Images were acquired in breath hold SSFP
sequences (TE 3.43; TR 1.72). Images were evalu-
ated with the cmr 42 research edition toolkit (Cir-
cle Cardiovascular Imaging, Calgary, Canada) com-
bining long and short axis views. The program cal-
culated end- and end-systolic volumes, as well as
stroke volume, EF and finally LV muscle mass, in-
dexed for body surface area. The relative wall thick-
ness was calculated from the posterior wall thick-
ness*2/LV end-diastolic diameter and considered
increased if > 0.42 [11]. Hypertrophy was defined
as LV mass index > 115 g/m2 body surface area in
men and > 95 g/m2 in women, whereas a relative
wall thickness > 0.42 was used as a cut-off for con-
centric or £ 0.42 for the eccentric remodeling or
hypertrophy, respectively.
The LV geometry was assessed from the LV
mass index and the relative wall thickness combi-
nation, and patients were subsequently subdivided
into four groups: normal geometry (Group 1), conce-
ntric remodeling (Group 2), eccentric hypertrophy
(Group 3) and concentric hypertrophy (Group 4).
Statistical analysis
All analyses were performed using SPSS sta-
tistical software (SPSS 17.0, Chicago, Illinois, USA).
The data is presented as mean ± SD unless other-
wise specified. A p-value < 0.05 was considered
statistically significant. Comparison of the two
groups of subjects for various parameters was per-
formed by one-way analysis of variance (ANOVA),
and Fisher-test was used for categorical variables.
When normality and/or equal variance testing con-
ditions were not met, the Kruskal-Wallis rank test
was used. Pearson’s linear correlation coefficients
were calculated for pairs of continuous variables.
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We first analyzed associations without any adjust-
ments, and then with adjustments for potential con-
founders by multiple linear regression for continu-
ous and logistic regression for categorical variables.
Results
Study population
Forty four patients with moderate to severe AS
and 40 age-matched controls without valvular heart
disease and with normal EF were included. In two
subjects with AS, MRI measurements were not
performed because of technical artefacts or claus-
trophobia. Furthermore, the echocardiographic
image quality was not sufficient to analyze longitu-
dinal myocardial strain in four subjects with AS
(5%). Therefore, both MRI measurements of LV
geometry and muscle mass in addition to echocar-
diographic determination of GLS were sufficient in
38 subjects. Standard echocardiography including
2D strain imaging was successfully performed in all
control patients. The baseline demographics and
clinical characteristics are highlighted in Table 1.
Demographics and clinical characteristics which
might have had an impact on LV geometry (i.e.
prevalence of hypertension) did not differ between
AS and controls.
Echocardiographic and MRI measurements
Echocardiographic and MRI measurement re-
sults are summarized in Table 2. In addition, GLS
values were obtained in a control group (n = 40).
According to the aortic valve area, 32 (84%) patients
were classified as having severe AS (aortic valve
area < 1.0 cm2), whereas the remaining six (16%)
subjects were identified with moderate AS (aortic
valve area 1–1.5 cm2). LV muscle mass measure-
ment by MRI reveals a normal LV muscle mass in
55% of subjects with AS (Groups 1 and 2). By sub-
dividing these patients according to the relative wall
thickness, 22% showed a normal LV geometry
(Group 1), whereas 34% were classified as having
concentric LV remodeling (Group 2). Increased LV
mass index was detected in 45% of the study group:
16% with eccentric hypertrophy (Group 3) and 29%
with concentric hypertrophy (Group 4).
One-way ANOVA analysis demonstrated that
the total group of patients with AS had significant-
ly reduced GLS values (–15.2 ± 3.6%), compared
to controls (–18.9 ± 3.7%, p < 0.001). Splitting
subjects with AS into Groups 1, 2, 3 or 4, the GLS
was –17.0 ± 2.4, –17.2 ± 2.7, –12.4 ± 3.8 and –12.4 ±
± 2.9%, respectively (Fig. 1, p = 0.002). The post-
hoc analysis (Bonferroni) showed a significant dif-
ference between Group 1 vs Group 3 (p = 0.041)
and between Group 1 vs Group 4 (p = 0.045) as
well as between Group 2 and Group 3 and Group 4
(p = 0.02 and p = 0.017), respectively. LV muscle
mass and GLS correlated significantly (r = 0.62,
p < 0.001) in subjects with moderate to severe AS.
The aortic valve area, mean pressure gradient,
EF and degree of diastolic dysfunction did not dif-
fer between Groups 1–4, respectively. In a multi-
ple linear regression analysis including age, gender,
history of hypertension, the presence of coronary
artery disease, LVEF or the history of myocardial
infarction and the mean transvalvular pressure gra-
dient, only LV geometry remained a significant pre-
dictor variable for the GLS impairment (b = 0.36,
p = 0.029). LVEF (determined with MRI) and GLS
(r = –0.42, p = 0.14) were not significantly corre-
lated.
Discussion
This is the first study to report a significant
association between echocardiographic analysis of
longitudinal myocardial function and the LV geo-
Table 1. Demographics, clinical and laboratory characteristics.
Variable Aortic stenosis vs controls Aortic stenosis
Aortic Controls P Group 1 Group 2 Group 3 Group 4 P
stenosis (n = 40) (n = 8) (n = 13) (n = 6) (n = 11)
(n = 38)
Age (mean ± SD) 73 ± 9 71 ± 8 0.31 74 ± 6 75 ± 4 70 ± 13 70 ± 13 0.49
Female 42% 50% 0.31 50% 46% 17% 45% 0.58
CAD 66% 67% 0.53 50% 54% 83% 81% 0.28
History of MI 10% 37% 0.005* 0% 8% 17% 18 0.57
Hypertension 87% 97% 0.09 88% 92% 83% 82% 0.88
CAD — coronary artery disease; MI — myocardial infarction; SD — standard deviation; *significant (p < 0.05); Group 1 — normal geometry; Group 2
— concentric remodeling; Group 3 — eccentric hypertrophy; Group 4 — concentric hypertrophy
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metry measured with MRI techniques in patients with
degenerative AS. LVH and reduced GLS were sig-
nificantly associated irrespectively of a preserved
EF, whereas the relative wall thickness (concentric
vs eccentric remodeling) did not have an impact on
the extent of longitudinal myocardial function impair-
ment. Furthermore, 2D GLS analysis seems to be
more sensitive than EF in detecting early myocar-
dial impairment, irrespective of the severity of AS.
Our findings align with the published literature
concerning this matter [12]. In a study of sub-clini-
cal patients with cardiovascular risk factors, LV
myocardial contraction was first impaired in the
longitudinal direction [13]. Particularly in patients
with severe AS, increased LV afterload induced
changes in LV geometry. As a consequence, LV wall
thickness increases to compensate for the elevat-
ed wall stress, maintaining normal EF [14].
In addition, an increased LV mass index was
found to be an independent predictor for the deve-
lopment of symptoms in patients with asymptomat-
ic AS [10]. Nevertheless, most publications on LV
geometry have been based on studies determining
LV geometry on echocardiographic measurements.
A major limitation on echocardiographic measure-
Table 2. Echocardiographic and magnetic resonance imaging (MRI) measurements in subjects with
aortic valve stenosis summarized. Left ventricular mass geometry measures were based on MRI
measurements.
Variable All patients Group 1 Group 2 Group 3 Group 4 P
(n = 38) (n = 8) (n = 13)   (n = 6)  (n = 11)
LVM [MRI, g/m2 BSA, SD] 86.2 ± 23 88 ± 12 85 ± 12 125 ± 14 120 ± 15 < 0.001*
Relative wall thickness 0.46 ± 0.1 0.35 ± 0.05 0.52 ± 0.09 0.38 ± 0.04 0.52 ± 0.07 < 0.001*
GLS baseline [%] –15.3 ± 3.6 –17.2 ± 2.4 –17.2 ± 2.7 –12.4 ± 3.9 –13.1 ± 3.3 0.002*
Vmax [cm/s] 434 ± 71 404 ± 41 443 ± 83 411 ± 65 457 ± 71 0.33
Pmax [mm Hg] 77 ± 26 65 ± 13 81 ± 31 69 ± 23 85 ± 26 0.33
Pmean [mm Hg] 45 ± 18 36 ± 8 47 ± 19 40 ± 17 51 ± 20 0.25
AVA [cm2] 0.85 ± 0.23 0.96 ± 0.16 0.85 ± 0.19 0.86 ± 0.24 0.78 ± 0.31 0.45
AVA index [cm2/m2 BSA] 0.47 ± 0.12 0.53 ± 0.76 0.47 ± 0.09 0.47 ± 0.14 0.43 ± 0.17 0.41
Severe AS [AVA < 1 cm2] 84% 88% 92% 83% 73% 0.61
E/A 1.1 ± 0.8 2.1 ± 0.5 0.9 ± 0.54 1.2 ± 1.4 1.2 ± 0.9 0.91
Smax [cm/s] 4.8 ± 1.3 5.1 ± 1.1 5.2 ± 1.4 4.1 ± 1.0 4.6 ± 1.4 0.31
E’ [cm/s] 4.5 ± 1.2 5.0 ± 1.3 4.8 ± 1.1 3.6 ± 1.6 4.4 ± 0.8 0.12
E/E’ 20.4 ± 8.6 17.6 ± 3.7 22.5 ± 10.6 22.3 ± 10.9 19.1 ± 7.1 0.56
CO [ECHO, L/min] 5.5 ± 1.3 5.6 ± 0.9 5.9 ± 1.3 4.8 ± 0.5 5.3 ± 1.9 0.41
SV [MRI, mL/min] 86 ± 22 94 ± 28 78 ± 20 90 ± 21 87 ± 20 0.44
EF [ECHO, %] 64 ± 12 67 ± 9 67 ± 9 53 ± 15 64 ± 14 0.09
EF [MRI, %] 68 ± 28 68 ± 9 80 ± 43 49 ± 11 63 ± 12 0.12
A — late mitral inflow velocity; AS — aortic stenosis; AVA — aortic valve area; BSA — body surface area; CO — cardiac output; E — early mitral
inflow velocity; E´— early tissue Doppler velocity at the septal mitral annulus; EF — ejection fraction; GLS — global longitudinal strain; LVM — left
ventricular mass index; MRI — magnetic resonance imaging; P — pressure; S — systolic tissue Doppler velocity at the septal mitral annulus;
SV — stroke volume; V — velocity; Group 1 — normal geometry; Group 2 — concentric remodeling; Group 3 — eccentric hypertrophy;
Group 4 — concentric hypertrophy; *statistically significant (p < 0.05)
ment of the LV geometry and muscle mass is that
the reproducibility of these measurements is prone
to imaging artefacts [1]. MRI is considered the stan-
dard method for the determination of LV geometry
because of its high spatial resolution and generally
good image quality [15, 16]. Therefore, we per-
formed LV geometry measurements with MRI  [1]
and GLS analysis with 2D echocardiography be-
cause of its higher temporal resolution and angle
independency [17]. Combining the advantages of
both methods, we believe that our results are re-
producible with minor measurement artefacts.
We found that patients with concentric or ec-
centric hypertrophy had the lowest average longi-
tudinal strain values, whereas there was no signi-
ficant difference between controls and patients with
concentric remodeling. These findings were inde-
pendent of gender, EF, history of hypertension, age
or severity of AS, indicating that increased LV
muscle mass is a stronger covariate of impaired lon-
gitudinal myocardial function than these variables.
In subjects with hypertension, concentric LVH has
been associated with depressed myocardial contrac-
tility, as well as worse clinical outcomes [18]. In
patients with AS, concentric hypertrophy has been
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found to be an independent predictor of higher in-
hospital mortality after aortic valve replacement
[19]. Despite the fact that hypertrophy helps to
maintain a normal EF, it also impairs coronary blood
flow reserve, which first occurs in the subendocar-
dial layers, which has been associated with in-
creased mortality [20, 21].
How can these results be interpreted? Since
the subendocardial myocardial fibers are oriented
longitudinally, and the impairment of myocardial
blood flow first occurs in the subendocardium, the
selective impairment in longitudinal myocardial
function observed in our study might be due to the
increase in subendocardial wall stress, leading to
ischemia and consecutive fibrosis. LVH develops
first as an adaptive response to maintain a normal
EF despite high LV afterload. While progressive
hypertrophy in AS has deleterious physiological
effects, concentric remodeling possibly reflects an
earlier phase in the remodeling process without
Figure 1. Global longitudinal strain values (%) in rela-
tion to left ventricular geometry in controls and patients
with aortic stenosis (AS). Figure 1 illustrates the range
of average peak longitudinal strain (%) in controls wi-
thout AS, in the whole study group with AS (n = 38),
and in the study group subdivided into normal geome-
try (Group 1), concentric remodeling (Group 2), eccen-
tric remodeling (Group 3) and concentric remodeling
(Group 4). Left ventricular geometry measurements
were done with magnetic resonance imaging; p < 0.001
for comparison between all groups by full-factorial
ANOVA analysis of variance; p < 0.001 for comparison
between average peak longitudinal strain in controls
and Group 3 and Group 4; p = 0.041 and p = 0.045 for
the comparison between Group 2 and Groups 3 and 4,
respectively.
impairments of myocardial contractile function.
Although the compensatory response to increased LV
afterload is initially beneficial, incipient hypertrophy
leads to impairments in myocardial function, which
cannot be detected with EF in the early stages.
Limitations of the study
There are several limitations to our study.
Firstly, MRI determination of LV geometry was not
done in the control group. Nevertheless, the con-
trol group only serves to provide a basis to obtain
normal GLS values in subjects without AS and com-
parable age and co-morbidities. Also, the impact of
antihypertensive treatment on deformation parame-
ters could not be assessed in the study.
Conclusions
Analysis of GLS provides a powerful means of
unmasking subtle myocardial dysfunction that is not
detected by EF in the early stages. This is of prac-
tical importance, since recent guidelines only focus
on LVEF in management decisions in patients with
degenerative AS. Our findings, in addition to pre-
vious works focusing on deformation analysis, jus-
tify the assessment of GLS in patients with AS, and
may identify patients who are in transition from
compensatory hypertrophy to myocardial failure.
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